Galaxy Medicare IPO Details
The key details of Galaxy Medicare’s IPO are outlined below, covering all crucial aspects from price range to investment requirements and regulatory documents.
| IPO Size | ₹22.31 Cr |
| Price Range | ₹51 - ₹54 |
| Retail Quota | 35% |
| QIB Quota | 50% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | NSE |
| Minimum Quantity | 4,000 |
| Investment (cut-off price) | ₹2,16,000 |
| Pre IPO Promotor Holding | 89.49% |
| Post IPO Promotor Holding | 64.60% |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Galaxy Medicare IPO Timelines
The IPO process for Galaxy Medicare includes key dates for participants to know. The timeline allows for strategic planning and participation, helping investors stay informed and engaged throughout the entire process.
10/09/2025
Start Date12/09/2025
End Date16/09/2025
Refund Initiation16/09/2025
Credit of Shares to Demat Ac17/09/2025
Listing DateGalaxy Medicare IPO Lot Size
The Galaxy Medicare IPO has a fixed lot size of 2,000 shares, at an upper price band of ₹54 per share. For retail investors, the minimum and maximum application is 4,000 shares (2 lots) amounting to ₹2,16,000. For Small HNI (S-HNI) investors, the minimum application is 6,000 shares (3 lots) worth ₹3,24,000, while the maximum is 18,000 shares (9 lots) amounting to ₹9,72,000. Big HNI (B-HNI) investors need to apply for at least 20,000 shares (10 lots), totaling ₹10,80,000.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 4000 | ₹2,16,000 |
| Retail Maximum | 2 | 4000 | ₹2,16,000 |
| S-HNI Minimum | 3 | 6000 | ₹3,24,000 |
| S-HNI Maximum | 9 | 18000 | ₹9,72,000 |
| B-HNI Minimum | 10 | 20000 | ₹10,80,000 |
Galaxy Medicare IPO Subscription Status
The subscription status for Galaxy Medicare IPO shows market demand across different investor categories, providing valuable insights into the offering’s performance. You can track real-time subscription data below.
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 1.00x | 1.48x | 2.10x | -- | 1.83x |
IPO Performance on Listing Day
On the listing day (September 17, 2025), Galaxy Medicare made a flat debut on the stock exchange. The stock opened at ₹54, exactly at par with its issue price. The healthcare company maintained this level as its day high but faced selling pressure throughout the trading session, declining to a low of ₹51.30. The shares concluded their first trading day at ₹51.30, which also became the day’s low, resulting in a decline of 5% from the issue price, indicating subdued investor sentiment toward the healthcare sector and concerns about market conditions for this medical services provider.
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹54.00 | ₹51.30 | ₹54.00 | ₹51.30 |
Galaxy Medicare IPO Company Financials
Galaxy Medicare reports robust performance in FY2025 September with Total Income of ₹17.78 crores, managing expenses at ₹15.36 crores, and achieving a strong PAT (Profit After Tax) of ₹ 1.71 crores, demonstrating significant growth potential ahead of its public offering.
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2022 | ₹30.74 | ₹29.29 | -₹0.21 |
| FY 2023 | ₹32.03 | ₹30.99 | ₹1.57 |
| FY 2024 | ₹36.94 | ₹32.62 | ₹3.71 |
| FY 2025 (6 M) | ₹17.78 | ₹15.36 | ₹1.71 |
About Company
Incorporated in July 1992, Galaxy Medicare Limited is a manufacturer and exporter of medical devices, plaster of Paris bandages, and surgical dressings in India. The company uses premium-grade raw materials sourced from trusted vendors to ensure the quality of its products. Its specialized offerings include surgical dressings, POP bandages, adhesive tapes, compression bandages, gauze products, orthopedic items, and a wide range of wound care solutions. These products are widely accepted by the medical community and are distributed across India to government health departments, corporate hospitals, and private healthcare providers. As of March 2025, Galaxy Medicare employs 190 people across various departments.
The company’s business model includes manufacturing and branding under its flagship brands such as POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE, GYPSONET, GYPSOCHLOR, and FIXCAN. It also serves as an OEM partner, designing and manufacturing medical products to brand owners’ specifications on a principal-to-principal basis. Galaxy Medicare participates in institutional sales through government tenders on the GEM Portal and exports its products internationally. With 27 registered trademarks in India, the company maintains a strong presence in both domestic and international markets. It adheres to ISO 9001:2015 and ISO 13485:2016 standards, ensuring its products meet the stringent requirements of healthcare institutions.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 1992 | Healthcare | Dilip Kumar Das |
Know Before Investing
Galaxy Medicare IPO Strengths
- Galaxy Medicare was founded in 1992 and has over three decades of experience in manufacturing medical devices and surgical dressings, providing a strong operational foundation.
- The company produces a wide range of medical consumables including Plaster of Paris bandages, medical tapes, sterile dressings, and absorbent gauze catering to various healthcare needs.
- Maintains long-term associations with hospitals, diagnostic centers, nursing homes, and other healthcare providers, leading to repeat business and customer loyalty.
- Owns a well-established manufacturing plant in Bhubaneswar equipped to produce a large volume and variety of medical products efficiently.
- Complies with stringent healthcare industry regulations and standards, mitigating risks of non-compliance and enhancing trust among clients.
- Supplies products not only within India but also exports to international markets, diversifying revenue streams.
Galaxy Medicare IPO Risks
- The company relies heavily on a limited number of large customers; losing any major client could significantly impact revenues and profitability.
- Significant funds are tied up in inventory and receivables, which can strain liquidity and cash flow, especially during economic slowdowns.
- Operating in the healthcare sector requires strict adherence to regulations and certifications; any non-compliance may result in penalties or operational restrictions.
- The medical devices and surgical consumables market is highly competitive with many established players, which may pressure pricing and market share.
- The company’s operations and sales are predominantly within certain geographic regions, which may limit growth potential and expose it to regional economic risks.
- Failure to keep pace with technological advancements and product innovation could reduce competitiveness in the fast-evolving medical device industry.
- Focus on a specific range of consumables may limit the company’s ability to mitigate risks associated with market saturation or demand shifts.
Swot Analysis for Galaxy Medicare IPO
Strengths
Strong Manufacturing Base, Robust Quality Assurance, Geographical Reach
Weaknesses
Limited Scale Compared to Large Multinationals, Dependence on Key Clients, Limited Digital Marketing Presence
Opportunities
Rising Healthcare Infrastructure, Expansion in Government Tender Business, Digitization and E-commerce
Threats
Intense Competition, Raw Material Cost Volatility, Counterfeit and Low-Quality Products
Company Details
Galaxy Medicare Ltd.
Plot No-2, Zone D, Phase A, Mancheswar Industrial Estate, Bhubaneswar, Khurda, Orissa, India-751010
Phone: +91 9937000991
Email: CS@galaxymed.co.in
Website: http://www.galaxy.in/
IPO Registar Details
Cameo Corporate Services Ltd.
Phone: +91-44-28460390
Email: investor@cameoindia.com
Website: https://ipo.cameoindia.com/
FAQs
The key objectives of Galaxy Medicare SME IPO are:
- Funding Capital Expenditure requirement towards purchase of machinery for the existing manufacturing facility at Bhubaneshwar, Odisha
- Funding the working capital requirements
- General Corporate Purposes
- To meet the offer related expenses
Affinity Global Capital Market Pvt. Ltd. is the book-running lead managers for the Galaxy Medicare IPO.
Galaxy Medicare IPO shows strong growth potential with FY24 revenue of ₹36.94 crore and PAT of ₹3.71 crore, delivering impressive ROE of 23.85 percent and ROCE of 23.80 percent. Rising global medical device demand, exports momentum, and capacity expansion initiatives strengthen its long-term scalability prospects.
The issue price for the Galaxy Medicare IPO is set between ₹51 to ₹54 per share.
To invest in two lot of Galaxy Medicare IPO, you need ₹2,04,000 at the lower price band (₹51 per share) or ₹2,16,000 at the upper price band (₹54 per share) for a lot size of 4000 shares.
Galaxy Medicare IPO shares are scheduled to be listed on the National Stock Exchange (NSE) on September 17, 2025.
Refund/unblocking of funds for Galaxy Medicare IPO will begin on September 16, 2025. ASBA/UPI blocks will be removed within 1 working day.
You can sell shares your Galaxy Medicare IPO shares on listing day (September 17, 2025) after they are credited to your demat account. If you want to sell in the pre-open market, the timing for that session is from 9:00 AM to 9:15 AM. Otherwise, you can sell after 10:00 AM during regular trading hours.